(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






6 Result: UnitedHealth

Rite Aid Seeks Chapter 11 Relief; Bullish View On UnitedHealth

October 16th, 2023

Rite Aid Corporation (NYSE: RAD) said that it has initiated a Chapter 11 filing, outlining a financial restructuring plan to reduce debt, increase financial flexibility, and support key business initiatives. The move aims to continue serving the near. Read more

Earnings Countdown: UnitedHealth, JPMorgan, and BlackRock in the Spotlight

October 08th, 2023

On Friday, October 13, three major companies are scheduled to unveil their financial results: UnitedHealth Group Incorporated (NYSE: UNH), a leading healthcare provider,  is set to unveil its third-quarter 2023 financial results before the op. Read more

Breaking: UK's CMA OKs £1.2bn UnitedHealth-EMIS Deal

September 29th, 2023

The Competition and Markets Authority (CMA) has given the green light to the £1.2 billion acquisition deal between healthcare tech companies UnitedHealth Group Inc. (NYSE: UNH) and EMIS, both of which provide critical services to the UK's Natio. Read more

FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices

June 08th, 2023

Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access Washington D.C. / CRWE PRESS RELEASE / June 8, 2023  -  As part of its ongoing study on pharmacy be. Read more

FibroGen Trial Disappoints, UnitedHealth Dividend Boost, Oracle and Ultragenyx Ratings Update

June 07th, 2023

FibroGen, Inc. (Nasdaq: FGEN) announced the topline data from the Phase 3 LELANTOS-1 trial, evaluating pamrevlumab as a treatment for non-ambulatory patients with Duchenne Muscular Dystrophy (DMD) on background corticosteroids.  Unfortunately. Read more

Exploring Analyst Views: Upside Potential for UnitedHealth, Strategic Education, UWM Holdings, CVS Health, Mirion Technologies, Integer

May 28th, 2023

Recent developments in the stock market have brought attention to several companies, with analysts and brokerage firms providing their views on potential price targets. These targets can give investors an idea of the potential upside of a stock based. Read more

Load More Content